Structure

Physi-Chem Properties

Molecular Weight:  492.24
Volume:  489.956
LogP:  2.747
LogD:  2.163
LogS:  -4.085
# Rotatable Bonds:  6
TPSA:  132.5
# H-Bond Aceptor:  9
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.483
Synthetic Accessibility Score:  5.063
Fsp3:  0.731
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.149
MDCK Permeability:  5.010252425563522e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.012
Human Intestinal Absorption (HIA):  0.248
20% Bioavailability (F20%):  0.028
30% Bioavailability (F30%):  0.781

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.863
Plasma Protein Binding (PPB):  67.30931854248047%
Volume Distribution (VD):  1.765
Pgp-substrate:  25.642934799194336%

ADMET: Metabolism

CYP1A2-inhibitor:  0.037
CYP1A2-substrate:  0.039
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.16
CYP2C9-inhibitor:  0.021
CYP2C9-substrate:  0.045
CYP2D6-inhibitor:  0.113
CYP2D6-substrate:  0.095
CYP3A4-inhibitor:  0.467
CYP3A4-substrate:  0.354

ADMET: Excretion

Clearance (CL):  2.62
Half-life (T1/2):  0.295

ADMET: Toxicity

hERG Blockers:  0.504
Human Hepatotoxicity (H-HT):  0.832
Drug-inuced Liver Injury (DILI):  0.836
AMES Toxicity:  0.032
Rat Oral Acute Toxicity:  0.864
Maximum Recommended Daily Dose:  0.081
Skin Sensitization:  0.244
Carcinogencity:  0.605
Eye Corrosion:  0.009
Eye Irritation:  0.012
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC88841

Natural Product ID:  NPC88841
Common Name*:   Caesalmin E
IUPAC Name:   [(1S,4aR,5S,6R,6aS,7S,11aS,11bS)-5,6-diacetyloxy-4a,7-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-1-yl] acetate
Synonyms:   caesalmin E
Standard InCHIKey:  ZMDJQZBKCANBDV-GZEDFXFRSA-N
Standard InCHI:  InChI=1S/C26H36O9/c1-13(27)33-19-8-10-23(4,5)26(31)22(35-15(3)29)21(34-14(2)28)20-17(24(19,26)6)12-18-16(9-11-32-18)25(20,7)30/h9,11,17,19-22,30-31H,8,10,12H2,1-7H3/t17-,19-,20-,21+,22-,24-,25+,26+/m0/s1
SMILES:  CC(=O)O[C@@H]1[C@@H]2[C@H](Cc3c([C@@]2(C)O)cco3)[C@@]2([C@]([C@H]1OC(=O)C)(O)C(C)(C)CC[C@@H]2OC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL517323
PubChem CID:   10480816
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[11678648]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[23806110]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[24303808]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11853 Eucalyptus froggattii Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7886 Eria tomentosa Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13248 Pistacia mexicana Species Anacardiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT336 Organism Human parainfluenza virus 3 Human parainfluenza virus 3 IC50 = 10.3 ug.mL-1 PMID[553258]
NPT27 Others Unspecified LC50 = 165.0 ug.mL-1 PMID[553258]
NPT27 Others Unspecified TI = 16.0 n.a. PMID[553258]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC88841 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC288602
0.9934 High Similarity NPC188649
0.9618 High Similarity NPC296558
0.9608 High Similarity NPC88007
0.9548 High Similarity NPC68848
0.949 High Similarity NPC121995
0.9481 High Similarity NPC194499
0.9481 High Similarity NPC195954
0.943 High Similarity NPC270312
0.9423 High Similarity NPC18986
0.9363 High Similarity NPC285567
0.9359 High Similarity NPC287559
0.9304 High Similarity NPC56358
0.9295 High Similarity NPC474611
0.929 High Similarity NPC41880
0.9241 High Similarity NPC283209
0.9236 High Similarity NPC8389
0.9221 High Similarity NPC121615
0.9221 High Similarity NPC294511
0.9216 High Similarity NPC228842
0.9216 High Similarity NPC212257
0.9177 High Similarity NPC79571
0.9177 High Similarity NPC200782
0.9177 High Similarity NPC82851
0.915 High Similarity NPC211625
0.9136 High Similarity NPC294512
0.9119 High Similarity NPC472773
0.9108 High Similarity NPC81405
0.9108 High Similarity NPC7059
0.9062 High Similarity NPC470182
0.9062 High Similarity NPC470940
0.9057 High Similarity NPC472771
0.9057 High Similarity NPC329938
0.9051 High Similarity NPC140952
0.9045 High Similarity NPC104736
0.9038 High Similarity NPC114880
0.9038 High Similarity NPC282445
0.902 High Similarity NPC71821
0.9018 High Similarity NPC475641
0.9018 High Similarity NPC475237
0.9012 High Similarity NPC160651
0.9006 High Similarity NPC86800
0.9006 High Similarity NPC277618
0.9 High Similarity NPC469338
0.9 High Similarity NPC292389
0.8987 High Similarity NPC472776
0.8987 High Similarity NPC299038
0.8987 High Similarity NPC472777
0.8987 High Similarity NPC304692
0.8987 High Similarity NPC472778
0.8987 High Similarity NPC249021
0.8981 High Similarity NPC264943
0.8974 High Similarity NPC476201
0.897 High Similarity NPC56953
0.897 High Similarity NPC176413
0.8951 High Similarity NPC173516
0.8951 High Similarity NPC472774
0.8951 High Similarity NPC472775
0.8944 High Similarity NPC469849
0.8944 High Similarity NPC276551
0.8944 High Similarity NPC276735
0.8931 High Similarity NPC475967
0.8916 High Similarity NPC472665
0.8903 High Similarity NPC69647
0.8903 High Similarity NPC125182
0.8896 High Similarity NPC271235
0.8896 High Similarity NPC255414
0.8896 High Similarity NPC471397
0.8896 High Similarity NPC291742
0.8896 High Similarity NPC255787
0.8889 High Similarity NPC470875
0.8889 High Similarity NPC472141
0.8889 High Similarity NPC475779
0.8882 High Similarity NPC302369
0.8882 High Similarity NPC39986
0.8882 High Similarity NPC477405
0.8882 High Similarity NPC134254
0.8875 High Similarity NPC472653
0.8875 High Similarity NPC477402
0.8868 High Similarity NPC261597
0.8868 High Similarity NPC36655
0.8868 High Similarity NPC167142
0.8868 High Similarity NPC472772
0.8861 High Similarity NPC476262
0.8854 High Similarity NPC469503
0.8839 High Similarity NPC19747
0.8834 High Similarity NPC472282
0.8834 High Similarity NPC473766
0.8834 High Similarity NPC473753
0.8831 High Similarity NPC62799
0.882 High Similarity NPC193798
0.882 High Similarity NPC263432
0.882 High Similarity NPC470792
0.882 High Similarity NPC69028
0.8812 High Similarity NPC477403
0.8812 High Similarity NPC307383
0.8805 High Similarity NPC469485
0.8797 High Similarity NPC30222
0.879 High Similarity NPC18135
0.8773 High Similarity NPC93172
0.8773 High Similarity NPC97574
0.8773 High Similarity NPC308156
0.8765 High Similarity NPC14499
0.8765 High Similarity NPC475039
0.8765 High Similarity NPC476197
0.8765 High Similarity NPC472139
0.8765 High Similarity NPC476035
0.8758 High Similarity NPC335761
0.8758 High Similarity NPC25255
0.875 High Similarity NPC45101
0.875 High Similarity NPC173544
0.8742 High Similarity NPC214541
0.8742 High Similarity NPC35000
0.8742 High Similarity NPC44675
0.8742 High Similarity NPC75310
0.8742 High Similarity NPC469336
0.8734 High Similarity NPC268905
0.8727 High Similarity NPC302392
0.8727 High Similarity NPC118086
0.8727 High Similarity NPC470995
0.8726 High Similarity NPC476122
0.872 High Similarity NPC472651
0.8712 High Similarity NPC261184
0.8712 High Similarity NPC476858
0.8712 High Similarity NPC476857
0.8712 High Similarity NPC271657
0.8712 High Similarity NPC476856
0.8704 High Similarity NPC470939
0.8704 High Similarity NPC149896
0.8704 High Similarity NPC5079
0.8704 High Similarity NPC207978
0.8704 High Similarity NPC18347
0.8696 High Similarity NPC475226
0.8693 High Similarity NPC263337
0.8688 High Similarity NPC107646
0.8679 High Similarity NPC178932
0.8679 High Similarity NPC253201
0.8679 High Similarity NPC302054
0.8667 High Similarity NPC472652
0.865 High Similarity NPC469846
0.865 High Similarity NPC234660
0.865 High Similarity NPC51568
0.865 High Similarity NPC198047
0.8645 High Similarity NPC5676
0.8642 High Similarity NPC475381
0.8636 High Similarity NPC476946
0.8636 High Similarity NPC64568
0.8634 High Similarity NPC187149
0.8634 High Similarity NPC470118
0.8634 High Similarity NPC286722
0.8616 High Similarity NPC33938
0.8616 High Similarity NPC472672
0.8616 High Similarity NPC475777
0.8614 High Similarity NPC82602
0.8608 High Similarity NPC469335
0.8608 High Similarity NPC159927
0.8608 High Similarity NPC477404
0.8608 High Similarity NPC196864
0.8606 High Similarity NPC476861
0.8606 High Similarity NPC476853
0.8606 High Similarity NPC476850
0.8606 High Similarity NPC310572
0.8605 High Similarity NPC472663
0.8605 High Similarity NPC472662
0.8598 High Similarity NPC27541
0.8598 High Similarity NPC472664
0.8598 High Similarity NPC62692
0.8598 High Similarity NPC476860
0.8598 High Similarity NPC61967
0.8598 High Similarity NPC123088
0.8598 High Similarity NPC126984
0.859 High Similarity NPC97904
0.8589 High Similarity NPC211777
0.8581 High Similarity NPC84479
0.8581 High Similarity NPC476944
0.858 High Similarity NPC475295
0.858 High Similarity NPC294149
0.858 High Similarity NPC478177
0.858 High Similarity NPC123153
0.858 High Similarity NPC473473
0.858 High Similarity NPC84349
0.8571 High Similarity NPC94763
0.8571 High Similarity NPC209364
0.8571 High Similarity NPC236004
0.8571 High Similarity NPC121158
0.8571 High Similarity NPC471437
0.8571 High Similarity NPC126723
0.8571 High Similarity NPC469576
0.8562 High Similarity NPC98206
0.8562 High Similarity NPC34421
0.8562 High Similarity NPC237259
0.8554 High Similarity NPC472765
0.8554 High Similarity NPC472766
0.8545 High Similarity NPC23387
0.8544 High Similarity NPC472654
0.8544 High Similarity NPC195325
0.8537 High Similarity NPC92589
0.8537 High Similarity NPC224394
0.8537 High Similarity NPC165218
0.8537 High Similarity NPC663

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC88841 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8929 High Similarity NPD8434 Phase 2
0.8509 High Similarity NPD5761 Phase 2
0.8509 High Similarity NPD5760 Phase 2
0.8193 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD7075 Discontinued
0.7989 Intermediate Similarity NPD6559 Discontinued
0.7987 Intermediate Similarity NPD4628 Phase 3
0.7952 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD7819 Suspended
0.7907 Intermediate Similarity NPD7473 Discontinued
0.7892 Intermediate Similarity NPD6801 Discontinued
0.7886 Intermediate Similarity NPD6764 Approved
0.7886 Intermediate Similarity NPD6765 Approved
0.7879 Intermediate Similarity NPD6599 Discontinued
0.7857 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7811 Intermediate Similarity NPD3749 Approved
0.7809 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD920 Approved
0.7759 Intermediate Similarity NPD3818 Discontinued
0.7738 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD6232 Discontinued
0.7732 Intermediate Similarity NPD8404 Phase 2
0.7725 Intermediate Similarity NPD7411 Suspended
0.7719 Intermediate Similarity NPD5494 Approved
0.7714 Intermediate Similarity NPD5844 Phase 1
0.7711 Intermediate Similarity NPD3226 Approved
0.7709 Intermediate Similarity NPD6785 Approved
0.7709 Intermediate Similarity NPD6784 Approved
0.7692 Intermediate Similarity NPD3817 Phase 2
0.7692 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD1934 Approved
0.7665 Intermediate Similarity NPD4380 Phase 2
0.7647 Intermediate Similarity NPD3882 Suspended
0.7622 Intermediate Similarity NPD6799 Approved
0.7602 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD8312 Approved
0.7598 Intermediate Similarity NPD8313 Approved
0.7593 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD5402 Approved
0.7578 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD2533 Approved
0.7576 Intermediate Similarity NPD2534 Approved
0.7576 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD2532 Approved
0.7574 Intermediate Similarity NPD37 Approved
0.7572 Intermediate Similarity NPD6959 Discontinued
0.7572 Intermediate Similarity NPD8127 Discontinued
0.7558 Intermediate Similarity NPD6234 Discontinued
0.7558 Intermediate Similarity NPD919 Approved
0.7546 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD4966 Approved
0.7544 Intermediate Similarity NPD4967 Phase 2
0.7544 Intermediate Similarity NPD4965 Approved
0.7543 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD6166 Phase 2
0.7529 Intermediate Similarity NPD2801 Approved
0.75 Intermediate Similarity NPD7458 Discontinued
0.7485 Intermediate Similarity NPD2800 Approved
0.7485 Intermediate Similarity NPD5403 Approved
0.7473 Intermediate Similarity NPD8150 Discontinued
0.7472 Intermediate Similarity NPD7074 Phase 3
0.747 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7768 Phase 2
0.743 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD1465 Phase 2
0.7425 Intermediate Similarity NPD6273 Approved
0.7423 Intermediate Similarity NPD1549 Phase 2
0.7416 Intermediate Similarity NPD7054 Approved
0.7416 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD1551 Phase 2
0.7407 Intermediate Similarity NPD2796 Approved
0.7407 Intermediate Similarity NPD6099 Approved
0.7407 Intermediate Similarity NPD6100 Approved
0.7391 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7472 Approved
0.7371 Intermediate Similarity NPD7199 Phase 2
0.7371 Intermediate Similarity NPD1247 Approved
0.7365 Intermediate Similarity NPD5401 Approved
0.7362 Intermediate Similarity NPD2346 Discontinued
0.7362 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD3751 Discontinued
0.736 Intermediate Similarity NPD7228 Approved
0.7348 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD2799 Discontinued
0.7333 Intermediate Similarity NPD3750 Approved
0.7317 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1511 Approved
0.7294 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD7251 Discontinued
0.7292 Intermediate Similarity NPD7435 Discontinued
0.7288 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD3926 Phase 2
0.7273 Intermediate Similarity NPD1243 Approved
0.7268 Intermediate Similarity NPD8407 Phase 2
0.7263 Intermediate Similarity NPD7799 Discontinued
0.7256 Intermediate Similarity NPD1471 Phase 3
0.7256 Intermediate Similarity NPD2344 Approved
0.7253 Intermediate Similarity NPD7808 Phase 3
0.7246 Intermediate Similarity NPD7236 Approved
0.7239 Intermediate Similarity NPD7033 Discontinued
0.7239 Intermediate Similarity NPD1510 Phase 2
0.7238 Intermediate Similarity NPD6797 Phase 2
0.7232 Intermediate Similarity NPD3787 Discontinued
0.7232 Intermediate Similarity NPD7229 Phase 3
0.7219 Intermediate Similarity NPD1512 Approved
0.7202 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD8368 Discontinued
0.7198 Intermediate Similarity NPD7685 Pre-registration
0.7195 Intermediate Similarity NPD2935 Discontinued
0.7188 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD2313 Discontinued
0.7188 Intermediate Similarity NPD3764 Approved
0.7186 Intermediate Similarity NPD6190 Approved
0.717 Intermediate Similarity NPD6832 Phase 2
0.7167 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD447 Suspended
0.716 Intermediate Similarity NPD6355 Discontinued
0.7135 Intermediate Similarity NPD6780 Approved
0.7135 Intermediate Similarity NPD6777 Approved
0.7135 Intermediate Similarity NPD6779 Approved
0.7135 Intermediate Similarity NPD6781 Approved
0.7135 Intermediate Similarity NPD6782 Approved
0.7135 Intermediate Similarity NPD6778 Approved
0.7135 Intermediate Similarity NPD7239 Suspended
0.7135 Intermediate Similarity NPD6776 Approved
0.7134 Intermediate Similarity NPD3748 Approved
0.7127 Intermediate Similarity NPD7286 Phase 2
0.7126 Intermediate Similarity NPD7003 Approved
0.7126 Intermediate Similarity NPD8166 Discontinued
0.7117 Intermediate Similarity NPD1607 Approved
0.7117 Intermediate Similarity NPD6651 Approved
0.7113 Intermediate Similarity NPD7497 Discontinued
0.7112 Intermediate Similarity NPD8361 Approved
0.7112 Intermediate Similarity NPD8360 Approved
0.7104 Intermediate Similarity NPD7240 Approved
0.7099 Intermediate Similarity NPD1240 Approved
0.7083 Intermediate Similarity NPD2309 Approved
0.7081 Intermediate Similarity NPD3268 Approved
0.7073 Intermediate Similarity NPD7097 Phase 1
0.7071 Intermediate Similarity NPD7874 Approved
0.7071 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7907 Approved
0.7055 Intermediate Similarity NPD230 Phase 1
0.7049 Intermediate Similarity NPD5953 Discontinued
0.7039 Intermediate Similarity NPD5711 Approved
0.7039 Intermediate Similarity NPD5710 Approved
0.7037 Intermediate Similarity NPD8032 Phase 2
0.703 Intermediate Similarity NPD4308 Phase 3
0.7029 Intermediate Similarity NPD8455 Phase 2
0.7026 Intermediate Similarity NPD7698 Approved
0.7026 Intermediate Similarity NPD7697 Approved
0.7026 Intermediate Similarity NPD7696 Phase 3
0.7024 Intermediate Similarity NPD4110 Phase 3
0.7024 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD8435 Approved
0.702 Intermediate Similarity NPD8151 Discontinued
0.7019 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7095 Approved
0.7006 Intermediate Similarity NPD1608 Approved
0.699 Remote Similarity NPD7870 Phase 2
0.699 Remote Similarity NPD8320 Phase 1
0.699 Remote Similarity NPD8319 Approved
0.699 Remote Similarity NPD7871 Phase 2
0.6981 Remote Similarity NPD2797 Approved
0.6979 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6975 Remote Similarity NPD6798 Discontinued
0.6975 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6974 Remote Similarity NPD6823 Phase 2
0.697 Remote Similarity NPD7701 Phase 2
0.6961 Remote Similarity NPD4111 Phase 1
0.6961 Remote Similarity NPD4665 Approved
0.695 Remote Similarity NPD7783 Phase 2
0.695 Remote Similarity NPD7801 Approved
0.695 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6005 Phase 3
0.6946 Remote Similarity NPD6004 Phase 3
0.6946 Remote Similarity NPD5762 Approved
0.6946 Remote Similarity NPD5763 Approved
0.6946 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6002 Phase 3
0.6937 Remote Similarity NPD5647 Approved
0.6933 Remote Similarity NPD6233 Phase 2
0.6931 Remote Similarity NPD4287 Approved
0.6919 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6914 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6908 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6907 Remote Similarity NPD8285 Discontinued
0.6899 Remote Similarity NPD9717 Approved
0.6891 Remote Similarity NPD8485 Approved
0.689 Remote Similarity NPD4140 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data